Results 191 to 200 of about 3,355,558 (275)
Opioid Modulation of Major Neurotransmitter Systems: Acute, Chronic, and Withdrawal Effects
Opioids are widely used but also frequently misused drugs that affect multiple neurotransmitter systems, including dopaminergic, glutamatergic, GABAergic, serotonergic, and cholinergic pathways. Opioid‐induced neuroadaptations depend on the duration of drug exposure, with distinct changes also emerging following drug discontinuation.
Daniela Novakova +2 more
wiley +1 more source
Testing oral nicotine pouches versus nicotine replacement therapy for cigarette harm reduction in Appalachia: The ARISE study protocol. [PDF]
Wermert A +10 more
europepmc +1 more source
ABSTRACT Aim To explore the influence of oral health‐related knowledge, attitudes and practices on oral health risk‐related behaviours of people in custodial settings. Design Integrative review. Data Sources Scopus, ProQuest Central, Web of Science, Medline, CINAHL, Academic Search Complete, PsycINFO and Education Research Complete were searched in ...
Izabella Barak +6 more
wiley +1 more source
Augmented Doses of Nicotine Replacement Therapy: Feasibility for Dual Cigarette and E-Cigarette Cessation. [PDF]
Palmer AM +6 more
europepmc +1 more source
Lipoprotein(a), Endothelial Dysfunction and Cardiovascular Disease
ABSTRACT Lipoprotein(a) (Lp(a)) is a particle similar to low‐density lipoprotein cholesterol and is associated with apolipoprotein (A). High Lp(a) levels are a genetic, independent risk factor for atherosclerotic cardiovascular disease (ASCVD). Endothelial cells, which form the continuous lining of the cardiovascular system, are crucial for vascular ...
Xianghui Zhou +5 more
wiley +1 more source
Effectiveness of Nicotine Replacement Therapy and Behavioral Intervention in Tobacco Cessation-A Tertiary Hospital-Based Randomized Controlled Trial. [PDF]
Mohanty UK +4 more
europepmc +1 more source
Abstract Conventional Swedish snus is used by millions in Scandinavia and increasingly worldwide, yet its cardiovascular effects remain poorly characterized. The emergence of nicotine pouches—commonly referred to as ‘white snus’ in Sweden—that deliver comparable nicotine without tobacco constituents adds complexity to a heterogeneous landscape and ...
Magnus Olsson +10 more
wiley +1 more source
GLP‐1 Receptor Agonists and Weight Loss: A Critical Review of Mechanisms
ABSTRACT GLP‐1 receptor agonist medications have the potential to promote marked weight loss, but maximal and sustained benefit may be compromised by poor compliance and cessation of use. Development of next‐generation medications that address current obstacles to effective use and development of effective adjunct treatments will benefit from better ...
Giorgia Rutigliani +8 more
wiley +1 more source
Nicotine replacement therapy: A review
C. K. Sumana +4 more
openaire +1 more source
Two randomized, single‐blind, placebo‐controlled crossover trials examined responses to non‐selective intravenous β‐AR stimulation (isoproterenol) in healthy adults, with co‐administration of an oral β3‐AR agonist (mirabegron; Study 1) or an intravenous antioxidant (vitamin C; Study 2).
Taylor R. Ewell +8 more
wiley +1 more source

